US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 53.900
  • -2.070-3.70%
Close Feb 14 16:00 ET
  • 53.790
  • -0.110-0.20%
Post 20:01 ET
109.38BMarket Cap-12.22P/E (TTM)

About Bristol-Myers Squibb Company

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Company Profile

SymbolBMY
Company NameBristol-Myers Squibb
Listing DateJun 1, 1969
Issue Price40.50
Founded1933
CEODr. Christopher S. Boerner, PhD
MarketNYSE
Employees34100
Fiscal Year Ends12-31
AddressRoute 206 & Province Line Road
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08543
Phone1-609-252-4621
Websitehttp://www.bms.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Christopher S. Boerner, PhD
  • Chairman of the Board and Chief Executive Officer
  • 8.46M
  • Amanda Ahn Poole
  • Executive Vice President and Chief People Officer
  • --
  • Dr. Robert M. Plenge, M.D.,PhD
  • Executive Vice President, Chief Research Officer and Head of Research
  • --
  • David V. Elkins
  • Executive Vice President and Chief Financial Officer
  • 7.17M
  • Dr. Samit Hirawat, M.D.
  • Executive Vice President, Chief Medical Officer and Head of Development
  • 6.23M
  • Gregory Scott Meyers
  • Executive Vice President, Chief Digital Officer and Chief Technology Officer
  • --
  • Adam Lenkowsky
  • Executive Vice President and Chief Commercialization Officer
  • --
  • Phil Holzer
  • Senior Vice President, Principal Accounting Officer and Controller
  • --
  • Sandra Leung
  • Executive Vice President and General Counsel
  • 5.92M
  • Cari Gallman
  • Executive Vice President, Corporate Affairs
  • --
  • Karin Shanahan
  • Executive Vice President, Global Product Development and Supply
  • --
  • Benjamin J. Hickey, M.B.A.
  • President, RayzeBio Organization
  • --
  • Lynelle Hoch
  • President, Cell Therapy Organization
  • --
  • Michael R. McMullen
  • Independent Director
  • --
  • Paula A. Price
  • Independent Director
  • 365.00K
  • Phyllis R. Yale
  • Independent Director
  • 365.00K
  • Dr. Julia A. Haller, M.D.
  • Independent Director
  • 371.68K
  • Theodore R. Samuels
  • Lead Independent Director
  • 425.00K
  • Dr. Deepak L. Bhatt, M.D.,M.P.H.
  • Independent Director
  • 329.97K
  • Peter J. Arduini
  • Independent Director
  • 359.68K
  • Dr. Karen H. Vousden, PhD
  • Independent Director
  • 344.74K
  • Derica W. Rice
  • Independent Director
  • 375.00K
  • Dr. Manuel Hidalgo Medina, M.D.,PhD
  • Independent Director
  • 335.00K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
HNAC Technology
300490
+19.20%
4
TFL
873152
+15.94%
5
Guangzhou LBP Medicine Science & Technology
688393
+13.41%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!